| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.6004/JNCCN.2010.0033 |
| P698 | PubMed publication ID | 20410336 |
| P2093 | author name string | Manish A Shah | |
| David P Kelsen | |||
| P433 | issue | 4 | |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 437-447 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Journal of the National Comprehensive Cancer Network | Q400309 |
| P1476 | title | Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease | |
| P478 | volume | 8 |
| Q54339340 | Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis. |
| Q34080247 | Adaptation to statins restricts human tumour growth in Nude mice |
| Q36330281 | Anti-VEGF therapies in the clinic |
| Q39067386 | Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review |
| Q35005752 | Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. |
| Q34094855 | Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). |
| Q44096113 | Can we resect EGC with Signet ring cells in Europe? |
| Q37832986 | Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard? |
| Q36158080 | Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer. |
| Q35050315 | Clinical evidence for three distinct gastric cancer subtypes: time for a new approach |
| Q26765314 | Clinical modalities for management of gastric cancer hepatic metastasis |
| Q26741530 | Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma |
| Q90117978 | Comparative analysis of HER2 copy number between plasma and tissue samples in gastric cancer using droplet digital PCR |
| Q37689114 | Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer : a propensity-matched analysis |
| Q38958732 | Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway |
| Q37087283 | Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer |
| Q60308871 | Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients |
| Q24187903 | Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer |
| Q24202230 | Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer |
| Q41242612 | Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis |
| Q47097970 | Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro. |
| Q46566535 | E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells |
| Q39143545 | Effects of legumain as a potential prognostic factor on gastric cancers |
| Q36579220 | Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma |
| Q34462350 | Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer |
| Q36687528 | Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile |
| Q35998729 | Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models |
| Q45144926 | Expression of the β3 subunit of Na+/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3/AKT pathway |
| Q35107984 | Gastric adenocarcinoma in children and adolescents |
| Q36753222 | Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis? |
| Q44734913 | Geographic difference in safety and efficacy of systemicchemotherapy for advanced gastric or gastroesophagealcarcinoma: a meta-analysis and meta-regression |
| Q97517700 | HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer |
| Q95777620 | HER2 Testing in Gastric/Gastroesophageal Junction Adenocarcinomas: Unique Features of a Familiar Test |
| Q90288998 | Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions |
| Q88955953 | Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells |
| Q55295718 | Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. |
| Q35854627 | Identification of low abundance microbiome in clinical samples using whole genome sequencing |
| Q28658552 | Imagine a world without cancer |
| Q64081314 | Immuno-checkpoint inhibitors in metastatic esophago-gastric cancer |
| Q41110505 | Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development. |
| Q28069873 | Immunotherapy for Gastroesophageal Cancer |
| Q38842511 | Immunotherapy for oesophagogastric cancer |
| Q83149832 | Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer |
| Q41146331 | Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010. |
| Q47780456 | Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer |
| Q64063438 | Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients |
| Q37704530 | Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population |
| Q37711639 | Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer |
| Q35616711 | Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways |
| Q35144943 | Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer |
| Q38804105 | MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19. |
| Q64269835 | MT1‑MMP promotes the proliferation and invasion of gastric carcinoma cells via regulating vimentin and E‑cadherin |
| Q35680094 | Management and outcome of gastric carcinoma in Zaria, Nigeria |
| Q34696685 | MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis |
| Q47677452 | MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma. |
| Q26764919 | Molecular alterations in gastric cancer with special reference to the early-onset subtype |
| Q38392332 | Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network |
| Q30500375 | Molecular classification of gastric cancer: a new paradigm |
| Q27016030 | Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward |
| Q37981607 | Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature |
| Q43508289 | Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients |
| Q38745185 | Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway |
| Q38220816 | Operable gastro-oesophageal junctional adenocarcinoma: Where to next? |
| Q55689581 | PROGNOSTIC VALUE OF CARCINOEMBRYONIC ANTIGEN LEVELS IN TRANSOPERATIVE PERITONEAL LAVAGE IN PATIENTS WITH GASTRIC CANCER. |
| Q36822182 | Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma |
| Q37092749 | Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer |
| Q36309934 | Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies |
| Q34008663 | RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer. |
| Q26777690 | Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma |
| Q38286373 | Ramucirumab: targeting angiogenesis in the treatment of gastric cancer. |
| Q41693807 | Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. |
| Q36649559 | Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil |
| Q37926527 | Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature |
| Q37133691 | Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis. |
| Q47101416 | SLC3A2, antigen of mAb 3G9, promotes migration and invasion by upregulating of mucins in gastric cancer |
| Q44961520 | Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer |
| Q41443108 | Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer. |
| Q39012091 | Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer |
| Q38653626 | Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions |
| Q38007119 | Targeted therapy for gastric cancer. |
| Q39403423 | The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis |
| Q35854625 | The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations |
| Q38929099 | The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression |
| Q90087481 | The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma |
| Q38942944 | The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma |
| Q87424140 | The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer |
| Q37809845 | Trastuzumab: in HER2-positive metastatic gastric cancer |
| Q37886993 | Update on HER2 testing for breast and upper gastrointestinal tract cancers |
| Q52921944 | Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics. |
| Q34305372 | Urushiol Induces Apoptosis via a p53-dependent Pathway in Human Gastric Cancer Cells |
| Q89953568 | Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trial |
| Q36529248 | c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells |
| Q37443693 | hsa-miR-376c-3p Regulates Gastric Tumor Growth Both In Vitro and In Vivo |
| Q48549971 | miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer |
| Q21245766 | miR-449 inhibits cell proliferation and is down-regulated in gastric cancer |
| Q33906199 | β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis |
Search more.